Thromboxane B2, 6-keto-PGF1α, PGE2, PGF2α, and PGA1 plasma levels in arteriosclerosis obliterans: Relationship to clinical manifestations, risk factors, and arterial pathoanatomy
- 1 January 1984
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 107 (1) , 45-52
- https://doi.org/10.1016/0002-8703(84)90132-7
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Platelet activation in clinical coronary artery disease and spasmAmerican Heart Journal, 1981
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- Increased fibrinopeptide A formation and thromboxane A2 production in patients with ischemic heart disease: Relationships to coronary pathoanatomy, risk factors, and clinical manifestationsAmerican Heart Journal, 1981
- Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.Circulation, 1980
- PROSTACYCLIN GENERATION IN ATHEROSCLEROTIC ARTERIESThe Lancet, 1979
- Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's anginaProstaglandins and Medicine, 1979
- UNSTABLE METABOLITES OF ARACHIDONIC ACID AND THEIR ROLE IN HAEMOSTASIS AND THROMBOSISBritish Medical Bulletin, 1978
- Vascular actinos of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dogEuropean Journal of Pharmacology, 1978
- Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in plateletsNature, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976